ArticlesBioPharma March 11, 2024 Bracing for a Future Wave of Advanced Therapies With the help of recent investor interest, progression of advanced therapy medicinal products... admin-element
Articles October 6, 2023 How can you harness the potential of nucleic acid therapeutics? At Cytiva, the new team is here to support you. We can help you throughout… admin-element
Articles March 24, 2023 Manufacturing mRNA for research and beyond This eBook guides you in the practical aspects of setting up an mRNA research laboratory. admin-element
ArticlesDownstream March 9, 2023 Modern plasmid purification process AcuraBio selects Cytiva's latest two-step purification protocol to offer a productive plasmid DNA... admin-element
ArticlesUpstream November 18, 2021 Scaling Up an E. coli Upstream Process for Plasmid DNA Production — from 2.5 to 160 L scale Fermenters This article summarizes the results of Escherichia coli growth performance for plasmid... admin-element
Articles October 21, 2021 mRNA Vaccines: Current Trends and Perspectives mRNA therapy is a rapidly growing field. The technology offers great benefit and potential for... admin-element
ArticlesRegulatory May 6, 2021 mRNA Processing Workflow for Vaccines and Therapeutics Learn more on key considerations when setting up a messenger RNA (mRNA) process with this… admin-element
Articles March 25, 2021 mRNA Therapeutics and Vaccines – Key Process Considerations Learn more on key considerations and strategies for process development and scaling up in our... admin-element
ArticlesBioPharmaRegulatory March 26, 2020 Can Vaccine Development Be Safely Accelerated? Human coronaviruses (HCoVs) in the past were considered to cause nothing more than the... admin-element